Drug Pipeline

Thymoglobulin Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
5
Recruiting
1
Phase 3
5
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT06872333
Allo HSCT for High Risk Hemoglobinopathies		 Trial arms changed: 4 -> 5
Active Studies by Phase
Phase 3
1
Phase 2
4
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06083129 Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in… GVHD Recruiting
Phase 2
NCT05735717 MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies Hematologic Malignancy Recruiting
NCT04888741 Methods of T Cell Depletion Trial (MoTD) Acute Myeloid Leukemia Recruiting
NCT06872333 Allo HSCT for High Risk Hemoglobinopathies Graft Failure Recruiting
NCT03292861 The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients Heart Transplantation Enrolling by Invitation
Phase 1
NCT07052370 TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of… Hematologic Malignancy Recruiting
Sponsors Running Thymoglobulin Trials
Masonic Cancer Center, University of Minnesota (2) Cedars-Sinai Medical Center (1) University of Birmingham (1) Assistance Publique - Hôpitaux de Paris (1) St. Jude Children's Research Hospital (1)
Disease Areas
Leukemia (2) Acute Myeloid Leukemia (AML) (2) Acute Lymphoblastic Leukemia (ALL) (2) Multiple Myeloma (1) Non-Hodgkin Lymphoma (1) Hodgkin Lymphoma (1) Myelodysplastic Syndromes (MDS) (1) Myelofibrosis (1) Sickle Cell Disease (1)
Get alerts when Thymoglobulin trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free